Search results for: 'Partnering Agreements with Actavis (formerly Watson Pharmacueticals) 2009-2014'
- Related search terms
- Partnering
- Partnering Agreement With
- partnering with
- Partnering Terms and Agreements in Diagnostics
- partnering agreements with optimer pharmaceutical 221b 221b
-
Precision Medicine Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Hospital Care Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Hospital Care Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2018-2024November 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More -
Immunology Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Immunology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Collaboration Deals in Pharmaceuticals 2019-2024September 2024$3,995.00Collaboration Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Stem Cell Collaboration and Licensing Deals 2010-2024November 2024$3,995.00Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More
